ELISA can detect Toxoplasma IgM antibody one year after infection in over 50% of patients. Therefore, IgM positive results should be evaluated further with one or two follow up samples if primary infection is suspected.

The Elisa test for diagnosis of tuberculosis using highly purified A 60 antigen extracted from mycobacteria

Positive/Negative

The ELISA (Enzyme-Linked Immunosorbent Assay) test for Anti-TB (Tuberculosis) IgM antibodies is used to detect the presence of IgM antibodies specific to Mycobacterium tuberculosis, the bacterium that causes tuberculosis. Here's how to interpret the results: Positive Result: A positive ELISA result indicates the presence of IgM antibodies specific to Mycobacterium tuberculosis in the blood sample. Interpretation: A positive result suggests recent or active infection with Mycobacterium tuberculosis. IgM antibodies typically appear during the early stages of infection or reactivation of tuberculosis. A positive result may indicate active tuberculosis disease, particularly in individuals with compatible clinical symptoms (such as cough, fever, night sweats, weight loss) and/or abnormal chest imaging findings. Negative Result: A negative ELISA result indicates the absence of detectable IgM antibodies specific to Mycobacterium tuberculosis in the blood sample. Interpretation: A negative result may occur if the individual has not been recently infected with Mycobacterium tuberculosis or if the test is performed during the early stages of infection before IgM antibodies develop. In some cases, particularly in individuals with compromised immune systems, IgM antibody production may be delayed or suppressed, leading to a false-negative result. Clinical Correlation: Interpretation of ELISA test results should be done in conjunction with the patient's clinical history, symptoms, exposure to tuberculosis, and other diagnostic tests (such as chest imaging and microbiological tests). A positive result, along with compatible clinical symptoms and other supportive diagnostic findings, may support a diagnosis of active tuberculosis disease. A negative result does not rule out tuberculosis, particularly in individuals with high clinical suspicion or risk factors for tuberculosis. Confirmation and Further Testing: In cases where clinical suspicion of tuberculosis is high despite a negative ELISA result, additional testing may be warranted. Additional tests, such as sputum smear microscopy, culture, molecular tests (e.g., PCR), or imaging studies (such as chest X-ray or CT scan), may help confirm the diagnosis and guide treatment. Limitations: It's important to recognize that the ELISA test for Anti-TB IgM antibodies has limitations, including the potential for false-positive or false-negative results. False-positive results may occur due to cross-reactivity with antibodies against other mycobacteria or non-tuberculous mycobacteria (NTM). False-negative results may occur if the test is performed during the early stages of infection before IgM antibody production or if the patient has an impaired immune response. Interpretation of the ELISA test for Anti-TB IgM antibodies should be performed by healthcare providers experienced in the diagnosis and management of tuberculosis. It's essential to consider the clinical context, symptoms, risk factors, and potential limitations of the test when interpreting results and determining appropriate treatment and management strategies.

Blood